Published in Virology on January 17, 2007
Systematic assembly of a full-length infectious clone of human coronavirus NL63. J Virol (2008) 1.23
Entry of herpes simplex virus type 1 (HSV-1) into the distal axons of trigeminal neurons favors the onset of nonproductive, silent infection. PLoS Pathog (2012) 1.02
A historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neurones. J Gen Virol (2008) 1.01
ICP0 dismantles microtubule networks in herpes simplex virus-infected cells. PLoS One (2010) 0.93
Development and pathogenic evaluation of recombinant herpes simplex virus type 1 expressing two fluorescent reporter genes from different lytic promoters. Virology (2008) 0.91
ICP0 antagonizes ICP4-dependent silencing of the herpes simplex virus ICP0 gene. PLoS One (2010) 0.86
Structure of the herpes simplex virus 1 genome: manipulation of nicks and gaps can abrogate infectivity and alter the cellular DNA damage response. J Virol (2014) 0.84
Fluorescent Protein Approaches in Alpha Herpesvirus Research. Viruses (2015) 0.82
Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice. J Virol (2017) 0.78
Roles of conserved residues within the pre-NH2-terminal domain of herpes simplex virus 1 DNA polymerase in replication and latency in mice. J Gen Virol (2014) 0.78
HSV-1 infection suppresses TGF-beta1 and SMAD3 expression in human corneal epithelial cells. Mol Vis (2008) 0.77
Visualization of mouse neuronal ganglia infected by Herpes Simplex Virus 1 (HSV-1) using multimodal non-linear optical microscopy. PLoS One (2014) 0.75
Gene Expression Correlates with the Number of Herpes Viral Genomes Initiating Infection in Single Cells. PLoS Pathog (2016) 0.75
Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol (1977) 41.93
FACS-optimized mutants of the green fluorescent protein (GFP). Gene (1996) 24.12
Herpes simplex virus type 1 ICP27 is an essential regulatory protein. J Virol (1985) 6.67
Use of the green fluorescent protein and its mutants in quantitative fluorescence microscopy. Biophys J (1997) 6.26
RELATIONSHIP BETWEEN THE ENVELOPE AND THE INFECTIVITY OF HERPES SIMPLEX VIRUS. Proc Soc Exp Biol Med (1964) 4.78
Transcriptional and genetic analyses of the herpes simplex virus type 1 genome: coordinates 0.29 to 0.45. J Virol (1984) 4.09
The promoter, transcriptional unit, and coding sequence of herpes simplex virus 1 family 35 proteins are contained within and in frame with the UL26 open reading frame. J Virol (1991) 4.01
The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency. J Virol (1993) 3.43
Nucleotide sequence specifying the glycoprotein gene, gB, of herpes simplex virus type 1. Virology (1984) 3.34
Efficiency of utilization of the simian virus 40 late polyadenylation site: effects of upstream sequences. Mol Cell Biol (1989) 3.26
A single amino acid change in the cytoplasmic domain alters the polarized delivery of influenza virus hemagglutinin. J Cell Biol (1991) 3.17
Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc Natl Acad Sci U S A (2002) 2.94
Comprehensive quantification of herpes simplex virus latency at the single-cell level. J Virol (1997) 2.51
Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice. J Virol (2002) 2.31
Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia. Virology (1996) 1.96
ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency. J Virol (2001) 1.96
Pathways of viral gene expression during acute neuronal infection with HSV-1. Virology (1992) 1.81
In situ DNA PCR and RNA hybridization detection of herpes simplex virus sequences in trigeminal ganglia of latently infected mice. Virology (1995) 1.77
Definition of the upstream efficiency element of the simian virus 40 late polyadenylation signal by using in vitro analyses. Mol Cell Biol (1992) 1.72
Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc Natl Acad Sci U S A (1999) 1.68
Mechanisms of herpes simplex virus type 1 reactivation. J Virol (1996) 1.49
Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants To establish wild-type levels of latency in vivo. J Virol (2000) 1.45
Immunohistochemical analysis of primary sensory neurons latently infected with herpes simplex virus type 1. J Virol (2000) 1.36
Basic statistical considerations in virological experiments. J Virol (2005) 1.32
Herpes simplex virus type 1 corneal infection results in periocular disease by zosteriform spread. J Virol (2001) 1.31
Green fluorescent protein is a quantitative reporter of gene expression in individual eukaryotic cells. FASEB J (2005) 1.26
Herpes simplex viral infection of the mouse trigeminal ganglion. Immunohistochemical analysis of cell populations. Invest Ophthalmol Vis Sci (1992) 1.23
Expression of the class III beta-tubulin isotype in developing neurons in culture. J Neurosci Res (1992) 1.23
Functional characterization of the HveA homolog specified by African green monkey kidney cells with a herpes simplex virus expressing the green fluorescence protein. Virology (1999) 1.12
Point mutations in herpes simplex virus type 1 oriL, but not in oriS, reduce pathogenesis during acute infection of mice and impair reactivation from latency. J Virol (2006) 1.10
Tracking the spread of a lacZ-tagged herpes simplex virus type 1 between the eye and the nervous system of the mouse: comparison of primary and recurrent infection. J Virol (2001) 1.07
Functionally significant secondary structure of the simian virus 40 late polyadenylation signal. Mol Cell Biol (2000) 1.05
Expression of beta-galactosidase in neurons of dorsal root ganglia which are latently infected with herpes simplex virus type 1. J Gen Virol (1995) 1.03
Re-evaluating natural resistance to herpes simplex virus type 1. J Virol (2004) 0.99
Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system. J Virol (2000) 0.96
Evidence that spontaneous reactivation of herpes virus does not occur in mice. Virol J (2005) 0.95
Herpes simplex virus latency analyzed by in situ hybridization. Curr Top Microbiol Immunol (1989) 0.90
A murine RNA polymerase I promoter inserted into the herpes simplex virus type 1 genome is functional during lytic, but not latent, infection. J Gen Virol (1996) 0.87
Immunohistochemical identification of trigeminal ganglion neurons that innervate the mouse cornea: relevance to intercellular spread of herpes simplex virus. J Comp Neurol (1993) 0.86
Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN-beta induction. Virology (2006) 1.56
Neither LAT nor open reading frame P mutations increase expression of spliced or intron-containing ICP0 transcripts in mouse ganglia latently infected with herpes simplex virus. J Virol (2002) 1.46
Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets. Nat Rev Drug Discov (2003) 1.28
Point mutations in herpes simplex virus type 1 oriL, but not in oriS, reduce pathogenesis during acute infection of mice and impair reactivation from latency. J Virol (2006) 1.10
The cyclin-dependent kinase inhibitor roscovitine inhibits the transactivating activity and alters the posttranslational modification of herpes simplex virus type 1 ICP0. J Virol (2002) 1.08
Phosphorylation site mutations affect herpes simplex virus type 1 ICP0 function. J Virol (2005) 1.08
ICP22 is required for wild-type composition and infectivity of herpes simplex virus type 1 virions. J Virol (2006) 1.02
Explant-induced reactivation of herpes simplex virus occurs in neurons expressing nuclear cdk2 and cdk4. J Virol (2002) 0.94
The differential requirement for cyclin-dependent kinase activities distinguishes two functions of herpes simplex virus type 1 ICP0. J Virol (2003) 0.91
Role of nuclear factor Y in stress-induced activation of the herpes simplex virus type 1 ICP0 promoter. J Virol (2010) 0.89
Transient expression of herpes simplex virus type 1 ICP22 represses viral promoter activity and complements the replication of an ICP22 null virus. J Virol (2009) 0.89
Cellular stress rather than stage of the cell cycle enhances the replication and plating efficiencies of herpes simplex virus type 1 ICP0- viruses. J Virol (2006) 0.88
Herpes simplex virus 1 ICP0 phosphorylation site mutants are attenuated for viral replication and impaired for explant-induced reactivation. J Virol (2011) 0.83
New anti-HSV therapeutics target the helicase-primase complex. Nat Med (2002) 0.82
Cathepsin B mediates cleavage of herpes simplex virus type 1 origin binding protein (OBP) to yield OBPC-1, and cleavage is dependent upon viral DNA replication. J Virol (2007) 0.82
Origin of expression of the herpes simplex virus type 1 protein U(S)1.5. J Virol (2009) 0.81
Glutamine deprivation causes enhanced plating efficiency of a herpes simplex virus type 1 ICP0-null mutant. J Virol (2008) 0.80